Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease
Bates, Evelyn A, Kipp, Zachary A, Martinez, Genesee J, Badmus, Olufunto O, Soundarapandian, Mangala M, Foster, Donald, Xu, Mei, Creeden, Justin F, Greer, Jennifer R, Morris, Andrew J, Stec, David E, Hinds, Jr, Terry D
Published in Biomolecules (Basel, Switzerland) (29.01.2023)
Published in Biomolecules (Basel, Switzerland) (29.01.2023)
Get full text
Journal Article
Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease
Badmus, Olufunto O., Silva, Alexandre A., Li, Xuan, Taylor, Lucy C., Greer, Jennifer R., Wasson, Andrew R., McGowan, Karis E., Patel, Parth R., Stec, David E.
Published in FASEB bioAdvances (01.05.2024)
Published in FASEB bioAdvances (01.05.2024)
Get full text
Journal Article
Abstract 14039: Therapeutic Potential of Beta Hydroxybutyrate in Nonalcoholic Fatty Liver Disease (NAFLD)-Induced Cardiovascular Disease
Badmus, Olufunto O, Taylor, Lucy C, Greer, Jennifer R, McGowan, Karis E, Hinds, Terry, Stec, David E
Published in Circulation (New York, N.Y.) (07.11.2023)
Published in Circulation (New York, N.Y.) (07.11.2023)
Get full text
Journal Article